Federated learning (FL) allows collaborative machine learning training without sharing private data. While most FL methods assume identical data domains across clients, real-world scenarios often involve heterogeneous data domains. Federated Prototype Learning (FedPL) addresses this issue, using mean feature vectors as prototypes to enhance model generalization. However, existing FedPL methods create the same number of prototypes for each client, leading to cross-domain performance gaps and disparities for clients with varied data distributions. To mitigate cross-domain feature representation variance, we introduce FedPLVM, which establishes variance-aware dual-level prototypes clustering and employs a novel $\alpha$-sparsity prototype loss. The dual-level prototypes clustering strategy creates local clustered prototypes based on private data features, then performs global prototypes clustering to reduce communication complexity and preserve local data privacy.

Survival analysis is an important research topic with applications in healthcare, business, and manufacturing. One essential tool in this area is the Cox proportional hazards (CPH) model, which is widely used for its interpretability, flexibility, and predictive performance. However, for modern data science challenges such as high dimensionality (both $n$ and $p$) and high feature correlations, current algorithms to train the CPH model have drawbacks, preventing us from using the CPH model at its full potential. The root cause is that the current algorithms, based on the Newton method, have trouble converging due to vanishing second order derivatives when outside the local region of the minimizer. To circumvent this problem, we propose new optimization methods by constructing and minimizing surrogate functions that exploit hidden mathematical structures of the CPH model. Our new methods are easy to implement and ensure monotonic loss decrease and global convergence. Empirically, we verify the computational efficiency of our methods. As a direct application, we show how our optimization methods can be used to solve the cardinality-constrained CPH problem, producing very sparse high-quality models that were not previously practical to construct. We list several extensions that our breakthrough enables, including optimization opportunities, theoretical questions on CPH's mathematical structure, as well as other CPH-related applications.

Large language models (LLMs) have demonstrated remarkable capabilities in language understanding and generation, leading to their widespread adoption across various fields. Among these, the medical field is particularly well-suited for LLM applications, as many medical tasks can be enhanced by LLMs. Despite the existence of benchmarks for evaluating LLMs in medical question-answering and exams, there remains a notable gap in assessing LLMs' performance in supporting patients throughout their entire hospital visit journey in real-world clinical practice. In this paper, we address this gap by dividing a typical patient's clinical journey into four stages: planning, access, delivery and ongoing care. For each stage, we introduce multiple tasks and corresponding datasets, resulting in a comprehensive benchmark comprising 12 datasets, of which five are newly introduced, and seven are constructed from existing datasets. This proposed benchmark facilitates a thorough evaluation of LLMs' effectiveness across the entire patient journey, providing insights into their practical application in clinical settings. Additionally, we evaluate three categories of LLMs against this benchmark: 1) proprietary LLM services such as GPT-4; 2) public LLMs like QWen; and 3) specialized medical LLMs, like HuatuoGPT2. Through this extensive evaluation, we aim to provide a better understanding of LLMs' performance in the medical domain, ultimately contributing to their more effective deployment in healthcare settings.

In the present study, we introduce an innovative structure for 3D medical image segmentation that effectively integrates 2D U-Net-derived skip connections into the architecture of 3D convolutional neural networks (3D CNNs). Conventional 3D segmentation techniques predominantly depend on isotropic 3D convolutions for the extraction of volumetric features, which frequently engenders inefficiencies due to the varying information density across the three orthogonal axes in medical imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). This disparity leads to a decline in axial-slice plane feature extraction efficiency, with slice plane features being comparatively underutilized relative to features in the time-axial. To address this issue, we introduce the U-shaped Connection (uC), utilizing simplified 2D U-Net in place of standard skip connections to augment the extraction of the axial-slice plane features while concurrently preserving the volumetric context afforded by 3D convolutions. Based on uC, we further present uC 3DU-Net, an enhanced 3D U-Net backbone that integrates the uC approach to facilitate optimal axial-slice plane feature utilization. Through rigorous experimental validation on five publicly accessible datasets--FLARE2021, OIMHS, FeTA2021, AbdomenCT-1K, and BTCV, the proposed method surpasses contemporary state-of-the-art models. Notably, this performance is achieved while reducing the number of parameters and computational complexity. This investigation underscores the efficacy of incorporating 2D convolutions within the framework of 3D CNNs to overcome the intrinsic limitations of volumetric segmentation, thereby potentially expanding the frontiers of medical image analysis.

Dual-target therapeutic strategies have become a compelling approach and attracted significant attention due to various benefits, such as their potential in overcoming drug resistance in cancer therapy. Considering the tremendous success that deep generative models have achieved in structure-based drug design in recent years, we formulate dual-target drug design as a generative task and curate a novel dataset of potential target pairs based on synergistic drug combinations. We propose to design dual-target drugs with diffusion models that are trained on single-target protein-ligand complex pairs. Specifically, we align two pockets in 3D space with protein-ligand binding priors and build two complex graphs with shared ligand nodes for SE(3)-equivariant composed message passing, based on which we derive a composed drift in both 3D and categorical probability space in the generative process. Our algorithm can well transfer the knowledge gained in single-target pretraining to dual-target scenarios in a zero-shot manner.

Bivariate partial information decomposition (PID) has emerged as a promising tool for analyzing interactions in complex systems, particularly in neuroscience. PID achieves this by decomposing the information that two sources (e.g., different brain regions) have about a target (e.g., a stimulus) into unique, redundant, and synergistic terms. However, the computation of PID remains a challenging problem, often involving optimization over distributions. While several works have been proposed to compute PID terms numerically, there is a surprising dearth of work on computing PID terms analytically. The only known analytical PID result is for jointly Gaussian distributions. In this work, we present two theoretical advances that enable analytical calculation of the PID terms for numerous well-known distributions, including distributions relevant to neuroscience, such as Poisson, Cauchy, and binomial.

Earth's'Gateway to Hell' keeps getting bigger Breakthroughs, discoveries, and DIY tips sent six days a week. In a remote area of the Siberian tundra, there's a place that locals call "The Gateway to Hell." In the summer, its peaceful waterfall sounds are interrupted by the booms and crashes of falling earth. The indigenous Yakut people are rightfully wary of the massive, slowly collapsing crater. Crater is an unsettling mark of our changing world.

We introduce, a brain dynamics foundation model with the Joint-Embedding Predictive Architecture (JEPA). This pioneering model achieves state-of-the-art performance in demographic prediction, disease diagnosis/prognosis, and trait prediction through fine-tuning. Furthermore, it excels in off-the-shelf evaluations (e.g., linear probing) and demonstrates superior generalizability across different ethnic groups, surpassing the previous large model for brain activity significantly.

As a popular paradigm for juggling data privacy and collaborative training, federated learning (FL) is flourishing to distributively process the large scale of heterogeneous datasets on edged clients. Due to bandwidth limitations and security considerations, it ingeniously splits the original problem into multiple subproblems to be solved in parallel, which empowers primal dual solutions to great application values in FL. In this paper, we review the recent development of classical federated primal dual methods and point out a serious common defect of such methods in non-convex scenarios, which we say is a ``dual drift'' caused by dual hysteresis of those longstanding inactive clients under partial participation training. To further address this problem, we propose a novel Aligned Federated Primal Dual (A-FedPD) method, which constructs virtual dual updates to align global consensus and local dual variables for those protracted unparticipated local clients. Meanwhile, we provide a comprehensive analysis of the optimization and generalization efficiency for the A-FedPD method on smooth non-convex objectives, which confirms its high efficiency and practicality. Extensive experiments are conducted on several classical FL setups to validate the effectiveness of our proposed method.

Co-crystallization is an accessible way to control physicochemical characteristics of organic crystals, which finds many biomedical applications. In this work, we present Generative Method for Co-crystal Design (GEMCODE), a novel pipeline for automated co-crystal screening based on the hybridization of deep generative models and evolutionary optimization for broader exploration of the target chemical space. GEMCODE enables fast co-crystal design with target tabletability profiles, which is crucial for the development of pharmaceuticals. With a series of experimental studies highlighting validation and discovery cases, we show that GEMCODE is effective even under realistic computational constraints. Furthermore, we explore the potential of language models in generating co-crystals. Finally, we present numerous previously unknown co-crystals predicted by GEMCODE and discuss its potential in accelerating drug development.